ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

KROS Keros Therapeutics Inc

60.57
3.47 (6.08%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Keros Therapeutics Inc KROS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
3.47 6.08% 60.57 09:00:00
개장가 저가 고가 종가 전일 종가
57.32 57.32 62.19 60.57 57.10
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
14/03/202421:00GLOBEKeros Therapeutics Announces U.S. FDA Fast Track Designation..
06/03/202422:01EDGAR2Form 8-K - Current report
05/03/202422:02EDGAR2Form 8-K - Current report
05/03/202422:01EDGAR2Form 8-K - Current report
05/03/202422:00GLOBEKeros Therapeutics to Present at Leerink Partners 2024..
29/02/202406:02EDGAR2Form 8-K - Current report
29/02/202406:01GLOBEKeros Therapeutics Reports Recent Business Highlights and..
24/02/202407:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202410:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202410:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202410:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/01/202422:00GLOBEKeros Therapeutics To Present at Pulmonary Vascular Research..
09/01/202422:01EDGAR2Form 8-K - Current report
09/01/202422:00GLOBEKeros Therapeutics Announces Closing of Upsized Public..
09/01/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:04EDGAR2Form 8-K - Current report
05/01/202406:04EDGAR2Form 144 - Report of proposed sale of securities
05/01/202406:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/01/202411:29GLOBEKeros Therapeutics Announces Pricing of Upsized Public..
04/01/202406:05GLOBEKeros Therapeutics Announces Proposed Public Offering of..
04/01/202406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/01/202422:04EDGAR2Form 8-K - Current report
11/12/202320:02EDGAR2Form 8-K - Current report
11/12/202320:00GLOBEKeros Therapeutics Presents Clinical Data from its KER-050..
07/11/202322:01EDGAR2Form 8-K - Current report
07/11/202322:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
06/11/202322:11EDGAR2Form 8-K - Current report
06/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202322:01EDGAR2Form 8-K - Current report
06/11/202322:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
02/11/202322:00GLOBEKeros Therapeutics to Present at the 65th American Society..
04/10/202321:01EDGAR2Form 8-K - Current report
04/10/202321:00GLOBEKeros Therapeutics Presents Preclinical Data from its..
05/09/202321:02EDGAR2Form 8-K - Current report
05/09/202321:00GLOBEKeros Therapeutics to Present at Upcoming Healthcare..
08/08/202305:02EDGAR2Form 8-K - Current report
07/08/202321:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202321:00EDGAR2Form 8-K - Current report
07/08/202321:00GLOBEKeros Therapeutics Reports Recent Business Highlights and..
28/07/202305:01GLOBECorrected: Keros Therapeutics to Host Conference Call and..
24/07/202321:01EDGAR2Form 8-K - Current report
24/07/202321:00GLOBEKeros Therapeutics to Host Conference Call and Webcast to..
12/06/202321:00GLOBEKeros Therapeutics Announces Update to Participation at the..
09/06/202319:00GLOBEKeros Therapeutics Presents Clinical Trial and Preclinical..
07/06/202321:00GLOBEKeros Therapeutics to Present at Goldman Sach’s 44th Annual..
22/05/202322:00GLOBEKeros Therapeutics Presents Preclinical and Clinical Data..
12/05/202305:01GLOBEKeros Therapeutics to Present at the 28th Annual Congress of..

최근 히스토리

Delayed Upgrade Clock